Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    - The Locations section was expanded to include numerous new study sites across the United States and internationally (including Argentina, Australia, Canada, and various European and Asian countries). This broadens access by showing more sites where the COSMIC-312 trial is conducted.
    Difference
    3%
    Check dated 2025-12-21T21:24:58.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    COSMIC-312 results have been posted on the study page, including updated PFS and OS outcomes, and related documents (Study Protocol and SAP) added to the record.
    Difference
    1%
    Check dated 2025-12-14T14:19:18.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a minor revision update: Revision: v3.3.2 replacing v3.3.1; there is no visible change to core study content, eligibility criteria, or study outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T03:05:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Publications section now states that items are automatically filled from PubMed. The revision history has been updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-23T00:41:22.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added a 'Results Submitted' status and updated two Taiwan locations from 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 736'.
    Difference
    0.2%
    Check dated 2025-11-15T15:31:07.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    No significant changes detected; the page content and structure appear the same as before, including study title, design, eligibility criteria, and locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-01T08:10:13.000Z thumbnail image

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.